Gland Pharma Appoints Surinder Koul as Head of Domestic Marketing & Raghuram Rao as Head of Quality
Gland Pharma Limited announced that Surinder Koul, currently serving as General Manager (Domestic Marketing), shall assume the role of Head of Domestic Marketing of the company and consequently will be a Senior Management Personnel (SMP) with effect from March 26, 2024. K Raghuram Chandra Rao, currently serving as Vice President (Quality Assurance), will take over as Head of Quality of the company with effect from March 30, 2024. Consequently, he would become a SMP of the company.
K.V.G.K. Raju, Chief Technical Officer and Head of Quality, will retire on March 29, 2024, and will cease to be an SMP. Susheel Ogra retired as Asst. Vice President and Head of Domestic Marketing on March 25, 2024, and ceased to be SMP. Prakash Vithal Baliga, Chief Operating Officer and SMP, has tendered his resignation to pursue other interests and opportunities. He will be relieved on April 30, 2024, and consequently, he will cease to be the SMP.
Surinder Koul joined Gland Pharma in March 2018 as National Sales Manager and rose to the level of General Manager. He has more than 26 years of experience in the marketing of pharmaceutical products. He started his career as a medical representative with ICPA Health Products and later worked with various organisations, viz., Sarabhai Chemicals, Centaur Pharmaceuticals, Anglo French & Drugs, and Ozone Pharmaceuticals, in different roles. He is a graduate from Kashmir University.
K. Raghuram Chandra Rao joined Gland Pharma in December 1999 as an Executive in Quality Assurance and rose to the level of VP. He has more than 25 years of experience in Quality Systems. He has been involved in developing and executing quality systems and designing the quality metrics to regulate the quality of medicines, specifically in the area of parenteral formulations. He has also been involved in the training and development of various aspects of quality systems. He is actively involved in Production Data Acquisition (PDA) in the knowledge-sharing process. He started his career in academics and worked for two years before moving into the industry. He worked for brief stints with AstraZeneca and Dr. Reddy’s Laboratories prior to joining Gland Pharma.